Tag: pediatric liver cancer
-
Genezen and Humane Genomics Forge Manufacturing Partnership to Accelerate Oncolytic Virus Therapy for Pediatric Liver Cancer
Strategic Collaboration to Accelerate Pediatric Cancer Treatments Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Humane Genomics, a biotechnology company focused on oncolytic viral therapies, announced a strategic partnership designed to advance manufacturing capabilities for a promising pediatric liver cancer program. The collaboration brings together Genezen’s proven expertise in scalable viral…
-
Genezen and Humane Genomics Announce Manufacturing Partnership to Advance Pediatric Liver Cancer Therapy
Overview of the Partnership Genezen, a leading viral vector CDMO, and Humane Genomics, a biotechnology company focused on oncolytic viral therapies, have unveiled a strategic manufacturing partnership aimed at accelerating the development and production of innovative treatments for pediatric liver cancer. The collaboration combines Genezen’s deep expertise in scale-ready viral vector manufacturing with Humane Genomics’…